Appropriate Timing of HAART in Co-infected HIV/TB Patients
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
To study the optimal timing to initiate antiretroviral therapy in HIV-infected patients who
are receiving tuberculosis treatment between at 4 weeks and at 12 weeks after tuberculosis
treatment by comparing the composite end point of death rate, hospitalization rate and
adverse drug reactions at week 48, 96 and 144.
Phase:
Phase 4
Details
Lead Sponsor:
Bamrasnaradura Infectious Diseases Institute
Collaborators:
Mahidol University Thai Red Cross AIDS Research Centre